Rare diseases
Investigational molecules
Locations
Back to Italy885 clinical trials in Prato, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer
ItalyStudy of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation
ItalyStudy on the Safety and Effectiveness of Bezuclastinib for Patients with Advanced Systemic Mastocytosis
ItalyStudy of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)
ItalyStudy Comparing Trabectedin and Gemcitabine for Patients with Advanced or Metastatic Leiomyosarcoma After Chemotherapy
ItalyStudy on the Effects of Somapacitan and Somatropin in Children with Growth Hormone Deficiency
ItalyStudy Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors
ItalyStudy of pirtobrutinib, venetoclax and rituximab combination compared to venetoclax and rituximab in previously treated Chronic Lymphocytic Leukemia patients
ItalyStudy of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2
ItalyStudy on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis
ItalyStudy of Zolbetuximab with Nab-Paclitaxel and Gemcitabine for Adults with Metastatic Pancreatic Cancer
ItalyStudy on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, including innovative therapies and maintenance strategies.
Multiple studies evaluating novel drug combinations and personalized treatment approaches for various breast cancer subtypes.
Innovative research in colorectal cancer and pancreatic cancer, exploring new treatment combinations and maintenance therapies.
Studies focus on improving survival rates and treatment effectiveness for advanced gastrointestinal cancers.
Research targeting ovarian cancer and related conditions, with emphasis on platinum-sensitive diseases and novel therapeutic combinations.
Trials exploring new approaches for treating various types of gynecologic cancers with innovative drug combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
